Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1987 Oct;80(4):1200–1204. doi: 10.1172/JCI113180

Molecular studies of ceruloplasmin deficiency in Wilson's disease.

M J Czaja 1, F R Weiner 1, S J Schwarzenberg 1, I Sternlieb 1, I H Scheinberg 1, D H Van Thiel 1, N F LaRusso 1, M A Giambrone 1, R Kirschner 1, M L Koschinsky 1, et al.
PMCID: PMC442366  PMID: 3654978

Abstract

Deficiency of serum ceruloplasmin is a characteristic biochemical abnormality of Wilson's disease, although the mechanism of this finding is unknown. Ceruloplasmin messenger RNA (mRNA) levels were therefore examined in five patients with Wilson's disease and five controls with other types of hepatic disease. Northern and dot blot hybridizations showed that detectable ceruloplasmin mRNA was present in all of the patients with Wilson's disease, including one patient with no detectable serum ceruloplasmin. However, the ceruloplasmin mRNA levels in the Wilson's disease patients were only 33% that of controls (P less than 0.001). In contrast, albumin mRNA levels in the Wilson's disease patients averaged 161% that of controls. In an attempt to better delineate the level of gene expression responsible for this decrease in ceruloplasmin mRNA, the nuclear run-on assay was used to analyze transcriptional rates. The amount of ceruloplasmin gene transcription in four Wilson's patients was decreased to 44% that of three controls. These results indicate that the diminished serum ceruloplasmin levels in patients with Wilson's disease are due at least in part to a decrease in ceruloplasmin gene transcription.

Full text

PDF
1200

Images in this article

1202Image
on p.1202
1202Image
on p.1202
1202Image
on p.1202

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bollen J., Seurynck D., Proesmans W., Fevery J., De Groote J. Ziekte van Wilson: Beschrijving van enkele gevallen. Tijdschr Gastroenterol. 1978;21(3):129–139. [PubMed] [Google Scholar]
  2. Bonné-Tamir B., Farrer L. A., Frydman M., Kanaaneh H. Evidence for linkage between Wilson disease and esterase D in three kindreds: detection of linkage for an autosomal recessive disorder by the family study method. Genet Epidemiol. 1986;3(3):201–209. doi: 10.1002/gepi.1370030307. [DOI] [PubMed] [Google Scholar]
  3. Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. doi: 10.1021/bi00591a005. [DOI] [PubMed] [Google Scholar]
  4. Clayton D. F., Darnell J. E., Jr Changes in liver-specific compared to common gene transcription during primary culture of mouse hepatocytes. Mol Cell Biol. 1983 Sep;3(9):1552–1561. doi: 10.1128/mcb.3.9.1552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Durnam D. M., Palmiter R. D. Transcriptional regulation of the mouse metallothionein-I gene by heavy metals. J Biol Chem. 1981 Jun 10;256(11):5712–5716. [PubMed] [Google Scholar]
  6. Epstein O., Sherlock S. Is Wilson's disease caused by a controller gene mutation resulting in perpetuation of the fetal mode of copper metabolism into childhood? Lancet. 1981 Feb 7;1(8215):303–305. doi: 10.1016/s0140-6736(81)91913-9. [DOI] [PubMed] [Google Scholar]
  7. Frydman M., Bonné-Tamir B., Farrer L. A., Conneally P. M., Magazanik A., Ashbel S., Goldwitch Z. Assignment of the gene for Wilson disease to chromosome 13: linkage to the esterase D locus. Proc Natl Acad Sci U S A. 1985 Mar;82(6):1819–1821. doi: 10.1073/pnas.82.6.1819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gibbs K., Walshe J. M. A study of the caeruloplasmin concentrations found in 75 patients with Wilson's disease, their kinships and various control groups. Q J Med. 1979 Jul;48(191):447–463. [PubMed] [Google Scholar]
  9. Gollan J. L., Stocks J., Dormandy T. L., Sherlock S. Reduced oxidase activity in the caeruloplasmin of two families with Wilson's disease. J Clin Pathol. 1977 Jan;30(1):81–83. doi: 10.1136/jcp.30.1.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Graul R. S., Epstein O., Sherlock S., Scheuer P. J. Immunocytochemical identification of caeruloplasmin in hepatocytes of patients with Wilson's disease. Liver. 1982 Sep;2(3):207–211. doi: 10.1111/j.1600-0676.1982.tb00198.x. [DOI] [PubMed] [Google Scholar]
  11. Hayek H. W., Knoll E., Widhalm S. Uber das organische Psychosyndrom bei Morbus Wilson (Langzeitbeobachtung mit psychologischen Testergebnissen bei 4 Patienten unter D-Penicillamintherapie. Monatsschr Kinderheilkd. 1973 Nov;121(11):679–683. [PubMed] [Google Scholar]
  12. Hofer E., Darnell J. E., Jr The primary transcription unit of the mouse beta-major globin gene. Cell. 1981 Feb;23(2):585–593. doi: 10.1016/0092-8674(81)90154-9. [DOI] [PubMed] [Google Scholar]
  13. Koschinsky M. L., Funk W. D., van Oost B. A., MacGillivray R. T. Complete cDNA sequence of human preceruloplasmin. Proc Natl Acad Sci U S A. 1986 Jul;83(14):5086–5090. doi: 10.1073/pnas.83.14.5086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Lawn R. M., Adelman J., Bock S. C., Franke A. E., Houck C. M., Najarian R. C., Seeburg P. H., Wion K. L. The sequence of human serum albumin cDNA and its expression in E. coli. Nucleic Acids Res. 1981 Nov 25;9(22):6103–6114. doi: 10.1093/nar/9.22.6103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Magzhanov R. V., Pertsev G. S., Trishina N. I. K diagnostike geterozigotnogo nositel'stva pri gepatotserebral'noi distrofii. Sov Med. 1979 Jul;(7):28–30. [PubMed] [Google Scholar]
  16. Mohrenweiser H. W., Decker R. S. Identification of several electrophoretic variants of human ceruloplasmin including CpMichigan, a new polymorphism. Hum Hered. 1982;32(6):369–373. doi: 10.1159/000153326. [DOI] [PubMed] [Google Scholar]
  17. Neifakh S. A., Vasiletz I. M., Shavlovsky M. M. Molecular pathology of ceruloplasmin. Biochem Genet. 1972 Apr;6(2):231–238. doi: 10.1007/BF00486406. [DOI] [PubMed] [Google Scholar]
  18. PORTER H. TISSUE COPPER PROTEINS IN WILSON'S DISEASE. INTRACELLULAR DISTRIBUTION AND CHROMATOGRAPHIC FRACTIONATION. Arch Neurol. 1964 Oct;11:341–349. doi: 10.1001/archneur.1964.00460220003001. [DOI] [PubMed] [Google Scholar]
  19. Ricca G. A., Hamilton R. W., McLean J. W., Conn A., Kalinyak J. E., Taylor J. M. Rat alpha 1-acid glycoprotein mRNA. Cloning of double-stranded cDNA and kinetics of induction of mRNA levels following acute inflammation. J Biol Chem. 1981 Oct 25;256(20):10362–10368. [PubMed] [Google Scholar]
  20. Shaposhnikov A. M., Zubzitski Y. N., Shulman V. S. Identification of ceruloplasmin in human liver cells by fluorescent antibodies and absence of this protein in Wilson disease. Experientia. 1969 Apr 15;25(4):424–426. doi: 10.1007/BF01899962. [DOI] [PubMed] [Google Scholar]
  21. Shokeir M. H., Shreffler D. C. Two new ceruloplasmin variants in Negroes--data on three populations. Biochem Genet. 1970 Aug;4(4):517–528. doi: 10.1007/BF00486602. [DOI] [PubMed] [Google Scholar]
  22. Summers J., Mason W. S. Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate. Cell. 1982 Jun;29(2):403–415. doi: 10.1016/0092-8674(82)90157-x. [DOI] [PubMed] [Google Scholar]
  23. Weiner F. R., Czaja M. J., Giambrone M. A., Takahashi S., Biempica L., Zern M. A. Transcriptional and posttranscriptional effects of dexamethasone on albumin and procollagen messenger RNAs in murine schistosomiasis. Biochemistry. 1987 Mar 24;26(6):1557–1562. doi: 10.1021/bi00380a010. [DOI] [PubMed] [Google Scholar]
  24. Yap S. H., Strair R. K., Shafritz D. A. Distribution of rat liver albumin mRNA membrane-bound and free in polyribosomes as determined by molecular hybridization. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5397–5401. doi: 10.1073/pnas.74.12.5397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Zern M. A., Leo M. A., Giambrone M. A., Lieber C. S. Increased type I procollagen mRNA levels and in vitro protein synthesis in the baboon model of chronic alcoholic liver disease. Gastroenterology. 1985 Nov;89(5):1123–1131. doi: 10.1016/0016-5085(85)90219-7. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES